Moreover, the study also found hypermethylation in the PDLIM2 promoter region, and methylation inhibitors or vitamin D treatment resulted in demethylation of the PDLIM2 promoter, leading to upregulated PDLIM2 expression and BC progression arrest [108]. This evidence concerns the gene PDLIM2 and breast cancer.